Contact Us
Leadership
Jonathan L. Curry, M.D.
Co-Director
Phone: 713-792-2956
Email: jlcurry@mdanderson.org
Jonathan L. Curry, M.D., is a dermatopathologist with international expertise in cutaneous toxicities. Curry is the Medical Director of the clinical histology laboratories in the department of Pathology. He is a faculty member of the TMP-IL and serves on the CIMAC working group. Additionally, he serves on the executive committee of the Immune-Oncology Toxicity (IO-TOX) Working group at MD Anderson. Curry will be the director of the TMP-DL and will be responsible for the administration of the laboratory activities. He will provide expertise and guidance in overall program direction and will oversee the research laboratory. Curry brings clinical and translational research expertise in skin toxicities to targeted and immune checkpoint inhibitor therapy and is a recipient of departmental and institutional research grants to investigate immune mechanisms of cutaneous toxicities. Curry’s research has revealed differentially expressed genes related to recruitment of CD14+ and CD16+ monocytes and Toll-like receptors (TLRs) activation in lichenoid skin toxicities and differentially expressed genes in bullous pemphigoid toxicities. Curry’s research team is positioned to further investigate the role of the innate immune response and immune mechanisms that drive cutaneous toxicities.
Carlos A. Torres Cabala, M.D.
Co-Director
Phone: 713-792-3151
Email: ctcabala@mdanderson.org
Carlos Torres-Cabala, M.D., is an internationally recognized dermatopathologist and translational researcher with special expertise in acral lentiginous melanoma and cutaneous lymphoma. Torres-Cabala serves as the Section Chief in Dermatopathology and has joint appointment in the Department of Dermatology. Torres-Cabala is a member of the Executive Committee of the International Society of Dermatopathology and serves in both the Review Committee for Clinical Translational and Population-based Research projects of the Institutional Research Grants Program and the Bridge Funding Advisory Committee at MD Anderson. Torres-Cabala represents MD Anderson at the T-cell and B-cell Primary Cutaneous Lymphoma Panel of the National Comprehensive Cancer Network (NCCN). Torres-Cabala’s research has recently reported mechanisms of melanoma progression to metastasis, such as TERT amplification, and clinicopathological features of rare lymphomas, such as epidermotropic primary cutaneous T cell lymphoma. Together with Jonathan L. Curry, M.D., Torres-Cabala edited a book, Genetics of Melanoma.
Staff
Courtney W. Hudgens
Sr. Research Assistant
Phone: 713-745-8235
Email: cwhudgens@mdanderson.org
Courtney W. Hudgens received her Bachelor’s of Science in Biology from Austin Peay State University in Clarksville, Tennessee. After graduation, she became a histotechnician in the clinical setting before moving over to diabetes research at Vanderbilt University Medical Center. She has a background in the fields of histology, serology and molecular biology. She joined MD Anderson in 2015.